Physicochemical Properties
| Molecular Formula | C9H12IN3O4 |
| Molecular Weight | 353.11 |
| Exact Mass | 352.987 |
| CAS # | 611-53-0 |
| PubChem CID | 65050 |
| Appearance | White to off-white solid powder |
| Density | 2.4±0.1 g/cm3 |
| Boiling Point | 522.1±60.0 °C at 760 mmHg |
| Melting Point | 185 °C |
| Flash Point | 269.6±32.9 °C |
| Vapour Pressure | 0.0±3.1 mmHg at 25°C |
| Index of Refraction | 1.815 |
| LogP | -0.69 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 17 |
| Complexity | 398 |
| Defined Atom Stereocenter Count | 3 |
| SMILES | IC1C(N([H])[H])=NC(N(C=1[H])[C@@]1([H])C([H])([H])[C@@]([H])([C@@]([H])(C([H])([H])O[H])O1)O[H])=O |
| InChi Key | WEVJJMPVVFNAHZ-RRKCRQDMSA-N |
| InChi Code | InChI=1S/C9H12IN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1 |
| Chemical Name | 4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidin-2-one |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. A Serpentier-Daude, Contact dermatitis to topical antiviral drugs. Ann Dermatol Venereol. 2000 Feb;127(2):191-3. |
| Additional Infomation |
Ibacitabine is a pyrimidine 2'-deoxyribonucleoside. Ibacitabine is an iodinated analog of deoxycytidine used topically in the treatment of herpes labialis. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (283.20 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.25 mg/mL (3.54 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.25 mg/mL (3.54 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 1.25 mg/mL (3.54 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 12.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.8320 mL | 14.1599 mL | 28.3198 mL | |
| 5 mM | 0.5664 mL | 2.8320 mL | 5.6640 mL | |
| 10 mM | 0.2832 mL | 1.4160 mL | 2.8320 mL |